Akari Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Akari Therapeutics is scheduled to report earnings on May 30, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Jun 22	Mar 22	Dec 21	Sep 21
Income Statement	-
Total Revenue	-	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	-	$ -5.82M	$ -5.24M	$ -5.87M	$ -1.46M
EBITDA	-	$ -5.82M	$ -5.24M	$ -5.87M	$ -1.46M
Net Income Common Stockholders	-	$ -5.68M	$ -5.18M	$ -5.79M	$ -1.45M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 13.20M	$ 8.15M	$ 16.72M	$ 9.36M	$ 13.39M
Total Assets	$ 13.83M	$ 11.37M	$ 19.45M	$ 11.65M	$ 14.72M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -13.20M	$ -8.15M	$ -16.72M	$ -9.36M	$ -13.39M
Total Liabilities	$ 12.04M	$ 3.05M	$ 5.52M	$ 6.09M	$ 3.36M
Stockholders Equity	$ 1.79M	$ 8.33M	$ 13.93M	$ 5.55M	$ 11.36M
Cash Flow	-
Free Cash Flow	-	$ -8.57M	$ -5.05M	$ -5.00M	$ -1.56M
Operating Cash Flow	-	$ -8.57M	$ -5.05M	$ -5.00M	$ -1.56M
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	$ 0.00	$ 12.37M	$ 1.12M	$ 11.18M

Currency in USD

Akari Therapeutics Earnings and Revenue History

Income Statement >

Akari Therapeutics Debt to Assets

Balance Sheet >

Akari Therapeutics Cash Flow

Cash Flow >

Akari Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing